A 16 Week Evaluation of the Novartis Health Management Tool (HMT) in Age Related Macular Degeneration (AMD)
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/14/2018 |
| Start Date: | January 11, 2011 |
| End Date: | November 30, 2011 |
A 16 Week Evaluation of the Novartis Health Management Tool in Assessing Self-test Visual Function in Patients With AMD Treated With Ranibizumab
This is a prospective pilot study to evaluate the usability and applicability of a self
monitoring test of visual function with the handheld Health Management Tool (HMT) to remotely
monitor neovascular Age Related Macular Degeneration (AMD) to detect a potential change in
disease status.
monitoring test of visual function with the handheld Health Management Tool (HMT) to remotely
monitor neovascular Age Related Macular Degeneration (AMD) to detect a potential change in
disease status.
Inclusion Criteria:
- Patients with CNV secondary to AMD and not other causes in at least one eye identified
by the investigator to be eligible for ranibizumab treatment
- Patients with a BCVA letter score in the study eye is 24 or better using an ETDRS
chart measured at 4 meters distance
Exclusion Criteria:
- Patients with any concurrent ocular condition that may result in visual loss during
the study
- Patients with past (within the prior 6 months) or current use of, or likely need for,
systemic medications that are known to be toxic to the lens, retina, or optic nerve
- Other protocol-defined inclusion/exclusion criteria may apply
We found this trial at
23
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Novartis Novartis, which was created in 1996 by the merger of the Swiss companies Ciba-Geigy...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Novartis Novartis, which was created in 1996 by the merger of the Swiss companies Ciba-Geigy...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials